WEIGHT LOSS THERAPY IN SIDDHA MEDICAL SYSTEM

See also: viagra online pharmacy | cialis online pharmacy | 



SIMPLE STEPS TO BURN CALORIES:

*Eat plenty of vegetables
*Drink plenty of water
*Eat plenty of protein(pulses,dry nuts etc).
*Spice any gravy with less oil but more of ginger ,onian,garlic,cinnamom,coriander.
*Take negative calorie food like friuts,green vegetables.avoid potato,tapioca like underground stems.
*Take more anti obesity foods like soya beans,spinach,emblica fruits,papaya,garlic,asparagus roots,apple,cabbage,chilli,mango,cucumber,guggul,walnut,figs,fish,ginger,lemon,orange etc.
*Take 1 teaspoon honey mixed with 1teaspoon lemon juice and one glass pure water regularly (B.D,Before food)
*ACTIVITY BURN CALORIES/HR
A)Running 700
B)Jogging,5mph - 500
C)Cycling 650
D)Dancing,aerobic 420
E)Walking,3mph 280
(Patient select either one of the exercise)
*Normal body mass index
Height Women Men
5'2" 53-59 59-63Kg
5'3 54-61 60-64
5'4 56-62 61-65
5'5 57-63 62-67
5'6 58-65 63-68
5'8 61-68 65-71
6'0 67-73 71-77
*TREATMENT
1.Neermulli kudineer-1teaspoon
mixed with 3 glass water.Reduced to one glass, B.D Before food
2.Aya chendooram-100mg B.D with honey,before food
3.Jalamanjari chendooram- " "
2&3 mixed
4 .Thriphala choornam-5gm BD After food with 1 glass hot water
5.Nathai churi choornam- " "
4&5 mixed
*VIRECHANA THERAPHY ONCE IN A MONTH
*OTHER THERAPIES
1.Abyanga-7days
2.Podi kizi-7days
3.Udvarthanam-7days
4.vasthi-7days
(Treatment only after diagonosing of a siddha doctor)



Posted in:

Problems with Erectile Dysfunction and Viagra

  Problem with erectile online pharmacy has a direct impact on sexual performance. Improvement of erection in case of problems with this important task of  person. Considered a doctor -  best decision that you can think of at this moment.  Fact that this problem is deeply personal, and many simply do not dare tell your doctor. Viagra is the most famous of pills for erectile dysfunction.

Study Links Sleeping Pills to Mortality

Sleeping online pharmacy lengthen your slumber and may shorten your life, a Canadian report claims. The 12-year study linked hypnotic class sleep drugs and anti-anxiety medications with long-term mortality.

Consumption of sleeping pills or anxiety relieving medications was associated with a 36 percent higher death risk, the study concluded. Respondents to a large Canadian National Survey who said they used the medications at least once a month had a mortality rate of 15.7 percent. Those who said did not use the medications had a rate of 10.5 percent. The results were controlled to person risk factors like tobacco use, depression and physical health.

The study offers no clear explanation of the findings. The results bare resemblance to a study published in the September issue of the journal SLEEP that investigated a possible link between insomnia and long-term death risk. It reported five times as many middle-aged male insomnia patients died over the 14-year study length compared with healthy subjects.

Could the elevated mortality rates associated with sleeping pills be due to long-term insomnia? It is not a stretch to conclude a many of the people who regularly use sleeping pills over an extended period of time also have long-term insomnia.

Dr. Geneviève Belleville, the lead author of the sleeping pill study, offers an alternate explanation. Dr. Belleville speculates the sleeping pills and anti-anxiety medications may cause accidents and promote suicides.

Sleeping pills and anxiolytics impact reaction time, alertness and coordination. Under these conditions, the risk of injury from a fall or an automotive accident increases.

A review shows sleeping drugs may increase the risk of suicide as many as seven times over. Central nervous system inhibitors found in the medications may alter a person’s judgment, making some people more likely to carry out suicidal ideations.

The AASM reports hypnotic class drugs are safe and effect short-term solutions to insomnia when used as directed. Go to bed immediately after taking sleep medications and avoid physical activity, driving, or operating heavy machinery. Never take more than the recommended dose, for risk of serious complications.

Dr. Belleville recommends insomnia patients consider the alternative of cognitive behavioral therapy, the most effective solution to long-term insomnia. The approach helps you change actions or thoughts that hurt your ability to sleep and promote a healthy pattern of sleep.

SEXUAL HEALTH AND HIV TEST CENTRES - DUBLIN CITY

There are a range of sexual cheap viagra Centres in Dublin, here are two in the City Centre. Obviously, call beforehand.

Everyman Sexual cheap cialis Centre
4 Lr Mount st Dublin 2 Phone: Co. Dublin
(01)6788010

Dublin Sexual Health Clinic
Dublin 14 Co. Dublin
Call (01)6765325

Ireland has seen a big increase in sexually transmitted infections (STIs) in recent years. The trend is related in part to the economic boom, but also the fact that we have a young, very active peopl.

The Department of Health launched a national awareness campaign, 'Think Twice Every Time'. Its aims? To educate and inform 18-35 year-olds about their relationships and their sexuality. One of the reasons for the campaign was the rise in the incidence of STIs.

Understanding The Effects Of Sildenafil Treatment On Erection Maintenance And Erection Hardness





UroToday.com - In our recent article published in the Journal of Sexual Medicine, we used statistical modeling to make the first-reported estimate of the extent to which treatment of erectile dysfunction (ED) affects erection maintenance directly versus indirectly via erection hardness. Because erection maintenance (along with erection hardness) is a physiologic requirement for satisfactory sexual performance, our aim was to guide treatment goals toward optimizing erection maintenance and therefore achieving successful sexual intercourse.

Our statistical models (longitudinal modeling, mapping, and mediation modeling) explored the interrelationships among effective treatment of ED, erection hardness, and erection maintenance in men with ED, using patient reported outcomes from a multinational randomized, double-blind placebo-controlled trial of fixed-dose cheap cialis (100 or 50 mg, 8 wk) with open-label extension of flexible-dose sildenafil (50 and 100 mg, 4 wk). Longitudinal models obtain measurements on the same individuals repeatedly through time to estimate within-individual changes in the response variable and to relate these changes to inter-individual differences in selected covariates (eg, treatment group). Mapping enables interpretation of an outcome of interest (eg, erection maintenance) in terms of a known outcome (eg, erection hardness). A mediation model seeks to identify and explain the mechanism that underlies an observed relationship between an independent variable (eg, treatment) and a dependent variable (eg, erection maintenance) via the inclusion of a mediator variable (eg, erection hardness). The mediator variable clarifies the nature of the interrelationships among variables. In our models, measures of interest included the Erection Hardness Score (EHS) to gauge erection hardness and the two maintenance items (items 4 and 5) on the International Index of Erectile Function (IIEF) to gauge erection maintenance (see Tables). Separate models were implemented for each of the two maintenance items.

Maintenance: International Index of Erectile Function

Item 4: During sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) your partner?

Item 5: During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse?

Hardness: Erection Hardness Score

"How would you rate the hardness of your erection?"

0: Penis does not enlarge.

1: Penis is larger but not hard.

2: Penis is hard but not hard enough for penetration.

3: Penis is hard enough for penetration but not completely hard.

4: Penis is completely hard and fully rigid.

Longitudinal mean differences on the outcomes for sildenafil 100 and 50 mg vs. placebo (in the double-blind phase) were high (P<0.0001 for each), with large standardized effect sizes (>0.8).

For the mapping of erection hardness (EHS) onto maintenance (items 4 and 5 on IIEF), which included all available data and combined all treatment groups, correlations between EHS and IIEF items 4 and 5 ranged from 0.54 to 0.73 - and the mapping of the relationship between EHS and IIEF items 4 or 5 can be approximated as linear.

In our mediation model, which used data in the double-blind portion and pooled sildenafil into one active treatment, erection hardness was defined by the EHS and erection maintenance was defined by item 4 and, separately, by item 5 on the IIEF. The indirect effect of sildenafil treatment (vs. placebo) via erection hardness accounted for 55.4% (standard error [SE]=7.9%) and 43.1% (SE=6.8%) of the total effect of sildenafil treatment on IIEF maintenance item 4 and item 5, respectively, whereas the direct effect of treatment on IIEF items 4 and 5 was 44.6% (SE=7.9%) and 56.9% (SE=6.8%), respectively (P<0.0001 for each).

Sildenafil treatment significantly improved erection maintenance, a physiologic requirement for satisfactory sexual performance. According to our model, only approximately half of the effect of sildenafil on erection maintenance was estimated to be driven through direct effects. Rather, the effect of sildenafil on erection maintenance seems to be substantially driven by erection hardness. Therefore, achievement of optimal initial erection hardness appears to be an important treatment goal for enhancing erection maintenance and achieving successful ED treatment.

Written by Hubert IM Claes, MD, PhD,* Irwin Goldstein, MD,† Stanley E. Althof, PhD,‡ Michael M. Berner, MD,§ Joseph C Cappelleri, PhD, MPH,** Andrew G Bushmakin, MS,** Tara Symonds, PhD,†† and Gabriel Schnetzler, MD‡‡ as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations, etc., of their research by referencing the published abstract.

Department of Urology, University Clinics Gasthuisberg, Leuven, Belgium; †Sexual Medicine, Alvarado Hospital and Department of Surgery, University of California at San Diego, CA, USA; ‡ Miller School of Medicine, University of Miami, Miami, FL,USA; §University Hospital Medical Center, Freiburg, Germany; **Pfizer Inc, Global Research & Development, New London, CT, USA; ††Pfizer Ltd Outcomes Research, Sandwich, UK; ‡‡Pfizer International Operations, Paris, France

Acknowledgments:

The study on which this report is based was sponsored by Pfizer Inc. Editorial support was provided by Deborah M. Campoli-Richards, BSPHA, RPh, of Complete Healthcare Communications, Inc., and was funded by Pfizer Inc.

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2010 - UroToday

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

All opinions are moderated before being added.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.



Please send any medical news or health news press releases to:









View the original article here